Viewing Study NCT05114603


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2026-01-02 @ 9:09 AM
Study NCT ID: NCT05114603
Status: UNKNOWN
Last Update Posted: 2022-05-03
First Post: 2021-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module